Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RZLT is expected to report earnings to fall 14.08% to -22 cents per share on November 06
Q3'25
Est.
$-0.22
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.09
The last earnings report on September 17 showed earnings per share of -25 cents, missing the estimate of -21 cents. With 1.21M shares outstanding, the current market capitalization sits at 763.86M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RZLT showed earnings on September 17, 2025. You can read more about the earnings report here.